- Home
- APLS vs CC Comparison
APLS vs CC Comparison
Compare APLS & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLS | CC |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | APLS | CC |
|---|---|---|
| Price | $20.64 | $18.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 9 |
| Target Price | ★ $31.79 | $18.11 |
| AVG Volume (30 Days) | 1.9M | ★ 3.7M |
| Earning Date | 04-02-2026 | 05-25-2026 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | ★ 112.50 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | $1,003,782,000.00 | ★ $6,638,000,000.00 |
| Revenue This Year | N/A | $7.02 |
| Revenue Next Year | $17.57 | $4.81 |
| P/E Ratio | $103.98 | ★ N/A |
| Revenue Growth | ★ 28.46 | 7.36 |
| 52 Week Low | $16.10 | $9.13 |
| 52 Week High | $30.48 | $21.85 |
Technical Indicators
Market Signals| Indicator | APLS | CC |
|---|---|---|
| Relative Strength Index (RSI) | 38.18 | 51.69 |
| Support Level | $18.95 | $13.88 |
| Resistance Level | $24.37 | $18.09 |
| Average True Range (ATR) | 0.97 | 1.45 |
| MACD | -0.14 | -0.38 |
| Stochastic Oscillator | 20.13 | 32.11 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.